nabi

oh, and btw, I don't care how good of a job they do with nicvax... I'll be long gone from the stock by then.

all I care about is the positive PR that will come from them STARTING the phase III trial on nicvax, or REPORTING the previously favorable result, which is GUARANTEED at some point (see the link to the reuters article), which will imho cause the return of the same investor enthusiasm that caused the stock to go to 14 in the first place.

For all I care they will probably fail phase III, but who cares? I'm playing this as a momo trade to 6$.

g/l
 
Back
Top